Stay tuned, leave your email
Articles récents
- Notice of the 2025 Annual General Meeting Published
- UZEDY® Accelerates: 2025 Revenue Outlook Raised to $190–$200M (from ~$160M); Olanzapine LAI on Track for Submission in 2025
- Medincell Proposes Board Appointments of Dr. Sharon Mates and Dr. Charles Kunsch
- Videoconference • Annual Results 2024-25
- Press Release: Consolidated Annual Financial Results
Commentaires récents
No comments to show.
